移植物抗宿主病
耐火材料(行星科学)
寄主(生物学)
医学
疾病
慢性病
重症监护医学
内科学
生物
遗传学
天体生物学
作者
Daniel Wolff,Corey Cutler,Stephanie J. Lee,Iskra Pusic,Henrique Bittencourt,Jennifer White,Mehdi Hamadani,Sally Arai,Amandeep Salhotra,José Antonio Pérez‐Simón,Amin M. Alousi,Hannah Choe,Mi Kwon,Arancha Bermúdez,Inho Kim,Gèrard Socié,Saurabh Chhabra,Vedran Radojčić,Timothy E. O’Toole,Chuan Tian
标识
DOI:10.1056/nejmoa2401537
摘要
Targeting CSF1R-dependent monocytes and macrophages with axatilimab resulted in a high incidence of response among patients with recurrent or refractory chronic GVHD. (Funded by Syndax Pharmaceuticals and Incyte; AGAVE-201 ClinicalTrials.gov number, NCT04710576.).
科研通智能强力驱动
Strongly Powered by AbleSci AI